DRK Blood Donation Service Baden-Württemberg – Hessen Starts INITIATE Study to Evaluate Pathogen-Inactivated Platelet Concentrates Treated with Cerus’ INTERCEPT™ Blood System in Routine Clinical Practice
Cerus (NASDAQ:CERS) had its "buy" rating reaffirmed by analysts at Cowen Inc.
Cerus Corporation Announces Preliminary Fourth Quarter and Full-Year 2025 Product Revenue and Provides Outlook [Yahoo! Finance]
Cerus Corporation Announces Preliminary Fourth Quarter and Full-Year 2025 Product Revenue and Provides Outlook
TD Cowen Sees Compelling Long-Term Value in Cerus Corporation (CERS) [Yahoo! Finance]